Donna is a transactional attorney with more than 20 years of specialized experience advising life sciences, biotechnology, manufacturing, technology, and commercial clients on a broad range of commercial, technology, and licensing matters.
Donna believes in fostering strong client relationships through deep industry understanding, clear communication, business-forward, practical advice, and a collaborative mindset.
Donna originally hails from Pennsylvania and started her career as a business associate at a large regional law firm in Philadelphia, where she practiced in the areas of securities, bankruptcy and corporate mergers and acquisitions. Early in her career, she went in-house at GlaxoSmithKline, where she supported the business development team in acquisitions and complex collaboration and licensing arrangements both within and outside the United States. She later transitioned to another Fortune 500 company in the Philadelphia area where she supported the lithium division of a large international chemical company. Donna has extensive experience working both as in-house counsel and as outside counsel, which allows her to advise and direct clients with a focus on practical solutions.
Donna is a proud alumna of the Pennsylvania State University, where she graduated with honors. After college, Donna spent a year abroad as a Fulbright Scholar to Spain. Upon returning home from Spain, Donna attended law school on a full scholarship at Ohio Northern University College of Law where she served as Editor for the Law Review and graduated first in her class. She is licensed to practice in Colorado and Pennsylvania.
Donna, along with her husband and three children, migrated to Colorado in 2020 to enjoy the beautiful scenery and the amazing skiing. When not working, Donna can be found either attending middle and high school sporting events, skiing, or golfing.
Recent Insights
KO Client Predicine Collaborates with Janssen to Develop PredicineCARE…
KO client Predicine, Inc., a leading molecular insights company committed to advancing precision medicine in oncology, recently…
Read MoreKO Client Cloudbreak Pharma Enters into Licensing Agreement with Sante…
KO client Cloudbreak Pharma, an innovative clinical-stage ophthalmology biotechnology company, recently announced that it has entered into…
Read MoreKO Attorneys Recognized in 2024 Edition of Best Lawyers: Ones to Watch…
Several of our attorneys have been recognized by their peers and included in the 2024 Edition of Best Lawyers: Ones…
Read More